Diagnostics Market Research Reports & Industry Analysis
The global diagnostics industry plays a critical role in disease prevention, detection, and treatment across a wide range of medical fields—and it’s also a big business with significant opportunities for growth and innovation. As the industry continues to change, staying up to date on the latest trends and insights is essential.
New Diagnostics Industry Reports Produced by Industry Experts
To help organizations understand the market on a deeper level and better navigate the shifting business landscape, MarketResearch.com offers a wide range of diagnostics market research reports. These studies cover both the in vitro diagnostics and medical imaging segments, providing information on market sizing, growth forecasts, market share, mergers and acquisitions, new product development, competitive analysis, and corporate profiling. With coverage of disruptive trends and emerging technologies, our reports give you the knowledge you need to stay ahead of market changes.
What Are the Benefits of Using MarketResearch.com?
- At MarketResearch.com, we understand the value of timely and reliable research. With over 20 years of experience in the field of market research, we have become a leading source of insights and analysis.
- We bring together reports from hundreds of leading firms, making it easy to find the information you need in one place.
- Our knowledgeable research specialists have worked closely with many top diagnostics industry companies and can offer personalized assistance to help you find reports that fit your research requirements.
- With our comprehensive coverage and expert analysis, you will be better positioned to gain a competitive edge in the global diagnostics industry.
Diagnostics Industry Research & Market Reports
-
Radiosurgery and Radiotherapy Robots
... 2030, growing at a CAGR of 4.8% over the analysis period 2024-2030. X-Ray Based Robots, one of the segments analyzed in the report, is expected to record a 5.3% CAGR and reach US$3.2 Billion by ... Read More
-
Refurbished Medical Equipment
... at a CAGR of 11.1% over the analysis period 2024-2030. Medical Imaging Equipment, one of the segments analyzed in the report, is expected to record a 12.3% CAGR and reach US$13.3 Billion by the end ... Read More
-
MRI Systems
... CAGR of 5.9% over the analysis period 2024-2030. Closed MRI Systems, one of the segments analyzed in the report, is expected to record a 6.0% CAGR and reach US$7.6 Billion by the end of the ... Read More
-
Microbiology Culture
... CAGR of 3.8% over the analysis period 2024-2030. Eukaryotic Culture, one of the segments analyzed in the report, is expected to record a 4.2% CAGR and reach US$5.2 Billion by the end of the analysis ... Read More
-
DNA Probes-Based Diagnostics
... at a CAGR of 9.4% over the analysis period 2024-2030. Infectious Diseases Application, one of the segments analyzed in the report, is expected to record a 9.2% CAGR and reach US$20.4 Billion by the end ... Read More
-
BioImaging Technologies
... CAGR of 15.0% over the analysis period 2024-2030. Medical Technology, one of the segments analyzed in the report, is expected to record a 14.7% CAGR and reach US$19.5 Billion by the end of the analysis ... Read More
-
First Aid Kits
... at a CAGR of 6.2% over the analysis period 2024-2030. Common Type Kit, one of the segments analyzed in the report, is expected to record a 6.2% CAGR and reach US$189.1 Million by the end ... Read More
-
Mobile Gamma Cameras
... at a CAGR of 4.2% over the analysis period 2024-2030. Single Head Mobile Gamma Camera, one of the segments analyzed in the report, is expected to record a 4.1% CAGR and reach US$45.4 Million by ... Read More
-
Electrophoresis Equipment and Supplies
... 2030, growing at a CAGR of 3.0% over the analysis period 2024-2030. Gel Electrophoresis Systems, one of the segments analyzed in the report, is expected to record a 2.7% CAGR and reach US$1.2 Billion by ... Read More
-
Clinical Diagnostics Automation
... at a CAGR of 6.5% over the analysis period 2024-2030. The U.S. Market is Estimated at US$1.5 Billion While China is Forecast to Grow at 10.6% CAGR The Clinical Diagnostics Automation market in the U.S. ... Read More
-
Research ELISA (Enzyme-Linked Immunosorbent Assay)
... Million by 2030, growing at a CAGR of 3.6% over the analysis period 2024-2030. ELISA Kits, one of the segments analyzed in the report, is expected to record a 3.4% CAGR and reach US$478.6 Million ... Read More
-
Full Body Scanners
... at a CAGR of 11.3% over the analysis period 2024-2030. Millimeter Technology, one of the segments analyzed in the report, is expected to record a 11.7% CAGR and reach US$609.0 Million by the end of ... Read More
-
Metabolic Testing Solutions
... at a CAGR of 6.8% over the analysis period 2024-2030. CPET Systems, one of the segments analyzed in the report, is expected to record a 5.6% CAGR and reach US$324.1 Million by the end of ... Read More
-
Women's Health Rehabilitation Products Market Analysis and Forecast to 2033: Type: (Physical Therapy, Occupational Therapy, Speech Therapy, Aquatic Therapy), Product: (Pelvic Floor Exercisers, Posture Correctors, Therapeutic Ultrasound Devices, Electrical Stimulation Devices, Compression Garments, Support Braces, Heat Therapy Products, Cold Therapy Products), Services: (Consultation Services, Rehabilitation Programs, Tele-rehabilitation, Home Care Services, In-patient Services, Out-patient Services, Customized Therapy Plans), Technology: (Wearable Technology, Mobile Health Apps, Virtual Reality, Artificial Intelligence, 3D Printing, Robotics), Component: (Hardware, Software, Services), Application: (Chronic Pain Management, Post-surgical Recovery, Pregnancy and Postpartum Care, Menopause Management, Injury Rehabilitation), Device: (Handheld Devices, Portable Devices, Stationary Devices), End User: (Hospitals, Clinics, Homecare Settings, Rehabilitation Centers), Functionality: (Monitori
... devices and solutions designed to aid recovery and improve quality of life for women experiencing health challenges. This market includes pelvic floor exercisers, maternity care products, and post-operative rehabilitation aids, addressing conditions such as postpartum ... Read More
-
Hepatitis Therapeutics
... CAGR of 3.7% over the analysis period 2024-2030. Hepatitis C Therapeutics, one of the segments analyzed in the report, is expected to record a 4.0% CAGR and reach US$17.8 Billion by the end of the ... Read More
-
Liver Cancer Diagnostics
... at a CAGR of 7.4% over the analysis period 2024-2030. Laboratory Tests, one of the segments analyzed in the report, is expected to record a 8.4% CAGR and reach US$9.8 Billion by the end of ... Read More
-
Medical Cyclotron
... CAGR of 10.6% over the analysis period 2024-2030. 16-18 MeV Cyclotron, one of the segments analyzed in the report, is expected to record a 10.4% CAGR and reach US$317.8 Million by the end of the ... Read More
-
Molecular Spectroscopy
... CAGR of 5.5% over the analysis period 2024-2030. Nuclear Magnetic Resonance Technology, one of the segments analyzed in the report, is expected to record a 7.5% CAGR and reach US$3.4 Billion by the end of ... Read More
-
Pediatric Imaging
... CAGR of 7.1% over the analysis period 2024-2030. Magnetic Resonance Imaging, one of the segments analyzed in the report, is expected to record a 7.5% CAGR and reach US$5.2 Billion by the end of the ... Read More
-
Glucose Biosensors
... CAGR of 2.1% over the analysis period 2024-2030. Hospitals End-Use, one of the segments analyzed in the report, is expected to record a 1.8% CAGR and reach US$1.5 Billion by the end of the analysis ... Read More
-
Gamma Knife
... CAGR of 4.5% over the analysis period 2024-2030. Malignant Tumors Indication, one of the segments analyzed in the report, is expected to record a 4.7% CAGR and reach US$221.1 Million by the end of the ... Read More
-
Predictive Genetic Testing and Consumer Genomics
... reach US$20.7 Billion by 2030, growing at a CAGR of 14.4% over the analysis period 2024-2030. Predictive Testing, one of the segments analyzed in the report, is expected to record a 14.3% CAGR and reach ... Read More
-
Reporter Gene Assays
... at a CAGR of 6.5% over the analysis period 2024-2030. Luciferase Assays, one of the segments analyzed in the report, is expected to record a 7.4% CAGR and reach US$4.6 Billion by the end of ... Read More
-
Artificial Intelligence (AI) in Medical Diagnostics
... reach US$4.4 Billion by 2030, growing at a CAGR of 22.2% over the analysis period 2024-2030. AI Software, one of the segments analyzed in the report, is expected to record a 24.0% CAGR and reach ... Read More
-
Blood Group Typing
... at a CAGR of 9.6% over the analysis period 2024-2030. Blood Group Typing Consumables, one of the segments analyzed in the report, is expected to record a 9.9% CAGR and reach US$2.8 Billion by the ... Read More
Research Assistance
